TrialThe Lancet. Infectious diseases2023

Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial.

Issaka Sagara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.